Ameritas Investment Partners’s Harvard Bioscience HBIO Stock Holding History

Ameritas Investment Partners’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-323	Closed	-$1.83K	–	3255
2025 Q1	$1.83K	Hold	323	–	–	﹤0.01%	3073
2024 Q4	$6.82K	Hold	323	–	–	﹤0.01%	2988
2024 Q3	$8.69K	Hold	323	–	–	﹤0.01%	2960
2024 Q2	$9.21K	Hold	323	–	–	﹤0.01%	2951
2024 Q1	$13.7K	Hold	323	–	–	﹤0.01%	2721
2023 Q4	$17.3K	Hold	323	–	–	﹤0.01%	2645
2023 Q3	$13.9K	Hold	323	–	–	﹤0.01%	2695
2023 Q2	$17.7K	Buy	+323	New	+$17.7K	﹤0.01%	2624
2022 Q2	–	Sell	-333	Closed	-$21K	–	3136
2022 Q1	$21K	Hold	333	–	–	﹤0.01%	2541
2021 Q4	$23K	Hold	333	–	–	﹤0.01%	2573
2021 Q3	$23K	Hold	333	–	–	﹤0.01%	2620
2021 Q2	$28K	Hold	333	–	–	﹤0.01%	2547
2021 Q1	$18K	Hold	333	–	–	﹤0.01%	2608
2020 Q4	$14K	Hold	333	–	–	﹤0.01%	2646
2020 Q3	$10K	Hold	333	–	–	﹤0.01%	2716
2020 Q2	$10K	Buy	+333	New	+$8.97K	﹤0.01%	2714
2019 Q2	–	Sell	-288	Closed	-$12K	–	3077
2019 Q1	$12K	Hold	288	–	–	﹤0.01%	2631
2018 Q4	$9K	Hold	288	–	–	﹤0.01%	2699
2018 Q3	$15K	Hold	288	–	–	﹤0.01%	2650
2018 Q2	$15K	Buy	+288	New	+$14.8K	﹤0.01%	2658

Other funds holding HBIO

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameritas Investment Partners's HBIO Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 323 shares — an estimated $1.83K sold.

Ameritas Investment Partners first reported a position in HBIO in Q2 2018 and held it in 20 quarters. The position peaked at $28K in Q2 2021. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

Ameritas Investment Partners reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 323 Harvard Bioscience shares in Q2 2025, an estimated $1.83K.
Ameritas Investment Partners first reported a position in Harvard Bioscience in Q2 2018 and held it in 20 quarters.
Ameritas Investment Partners's Harvard Bioscience position peaked at $28K in Q2 2021.
68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.